BioXcel Therapeutics, Inc.·4

Jan 12, 7:08 PM ET

Patni Rajiv 4

4 · BioXcel Therapeutics, Inc. · Filed Jan 12, 2026

Insider Transaction Report

Form 4
Period: 2026-01-09
Patni Rajiv
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1]
    2026-01-09+17,00017,000 total
    Exercise: $2.01Exp: 2036-01-09Common Stock (17,000 underlying)
Footnotes (1)
  • [F1]The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.
Signature
/s/ Richard Steinhart, Attorney-in-Fact for Rajiv Patni|2026-01-12

Documents

1 file
  • 4
    tm262917-6_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT